Cellular changes in hepatocytes and intestinal endothelium after hepatoduodenal ligament occlusion and protective effects of caspase inhibition

Annals of Surgery

Volumn 253, Issue 3, 2011, Pages 561-565

  Sheen Chen, Shyr Ming ^a,c   Su, Feng I ^a   Tang, Rei Ping ^b   Huang, Chao Cheng ^a   Eng, Hock Liew ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c XIAMEN CHANG GUNG HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BENZYLOXYCARBONYLVALYLALANYLASPARTIC ACID FLUOROMETHYLKETONE; CASPASE; HERMES ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL PROTECTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; HEPATODUODENAL LIGAMENT OCCLUSION; IMMUNOHISTOCHEMISTRY; INTESTINE CELL; INTESTINE FUNCTION; INTESTINE OBSTRUCTION; JEJUNUM; LIVER; LIVER CELL; LIVER FUNCTION; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; ANTIGENS, CD44; APOPTOSIS; CASPASES; CYSTEINE PROTEINASE INHIBITORS; HEPATECTOMY; HEPATOCYTES; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; INTESTINAL MUCOSA; INTESTINES; ISCHEMIA; JEJUNUM; LIGAMENTS; LIVER; MALE; PORTAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79951670999     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31820652f4     Document Type: Article

References (39)

1. Wobbes T, Bemelmans BLH, Kuypers JHC, et al. Risk of postoperative septic complications after abdominal surgery treatment in relation to perioperative blood transfusion. Surg Gynecol Obstet. 1990;171:5962-5965
2. Makuuchi M, Mori T, Gunven P, et al. Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet. 1989;130:824-831
3. Negorney DM HJ, Illstrup DM, Adson MA. Primary hepatic malignancy: surgical management and determinants of survival. Surgery. 1989;106: 740-749 (Pubitemid 19255085)
4. Horiuchi T, Muraoka R, Tabo T, et al. Optimal cycles of hepatic ischemia and reperfusion pedicle clamping during liver surgery. Arch Surg. 1995;130: 754-758
5. Hardy KJ, Tancheroen S, Shulkes A. Comparison of continuous versus intermittent ischemia-reperfusion during liver resection in an experimental model. Br J Surg. 1995;82:833-836
6. Belghiti J, Noun R, Malafosse R, et al. Continuous versus intermittent portal triad clamping for liver resection. A controlled study. Ann Surg. 1999;229: 369-375 (Pubitemid 30191772)
7. Isozaki H, Adam R, Gigou M, et al. Experimental study of the protective of intermittent hepatic pedicle clamping in the rat. Br J Surg. 1992;79:310-313
8. Hewitt G, Halliday I, MacCaigue M, et al. Modtality, endotoxeaemia and cytokine expression after intermittent and continuous hepatic ischemia. Br J Surg. 1995;82:1424-1426
9. Souba WW, Smith Rj, Wilmore DW. Glutamine metabolism by the intestinal tract. JPEN. 1985;9:608-616
10. Kaiserlian D, Vidal K. Antigen presentation by intestinal epithelial cells. Immunol Today. 1993;14:144 (Pubitemid 23068304)
11. Arnaiz-Villena, Perez-Blas M, Corell A, et al. Cell surface phenotype and ultramicroscopic analysis of purified human enterocytes: a possible antigen-presenting cell in the intestine. Tissue Antigens. 1997;50:586-592 (Pubitemid 28005831)
12. Marin ML, Greenstein AJ, Geller SA, et al A freeze fracture study of Crohn's disease of the terminal ileum: changes in epithelial tight junction organization. Am J Gastroenterol. 1983;78:537-547 (Pubitemid 13000935)
13. Butcher EC. The regulation of lymphocyte traffic. Curr Top Microbiol Immunol. 1986;128:85-122
14. Haynes BF, Telen MJ, Hole LP, et al. CD44-A molecule involved in leukocyte adherence and T-cell activation. Immunol Today. 1989;10:423-438
15. Arch R, Wirth K, Hofmann M, et al. Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science. 1992;257:682-685
16. Gunther U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 1991;65:13-24 (Pubitemid 121001209)
17. Miyake L, Medina KL, Hayasi SI, et al. Monoclonal antibodies to Pgp-1/CD44 block lymphohematopoiesis in long term bone marrow cultures. J Exp Med. 1990;171:477-488 (Pubitemid 20059042)
18. Screaton GR, Bell MV, Jackson DG, et al. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA. 1992;89:12160-12164 (Pubitemid 23004805)
19. Denning SM, Le PT, Singer KH, et al. Antibodies against the CD44 P80, lymphocyte homing receptor molecule augment humanPeripheral blood T cell activation. J Immunol. 1990;144:7-15 (Pubitemid 20030451)
20. Webb DSA, Shimizu Y, Van Seventer GA, et al. LFA-3, CD44 and CD45: physiologic triggers of human monocyte TNF and IL-1 release. Science. 1990;249:295-1297
21. Jacobson K, O'dell D, Holifield B, et al. Redistribution of a major cell surface glycoprotein during cell movement. J Cell Biol. 1984;99:1613-1623 (Pubitemid 15223597)
22. Kremmidiotis G, Zola H. Changes in CD44 expression during B cell differentiation in the human tonsil. Cell Immunol. 1995;161:147-157
23. Galandrini R, Piccoli M, Frati I, et al. Tyrosine kinase-dependent activation of human NK cell function upon triggering through CD44 receptor. Eur J Immunol. 1996;26:2807-2811 (Pubitemid 26411481)
24. RafiA, NagarkattiM,Nagarkatti PS. Hyaluronate-CD44 interaction can induce murine B-cell activation. Blood. 1997;89:2901-2908 (Pubitemid 27172577)
25. Alho AM, Underhill CB. The hyaluronate receptor is preferentially expressed on proliferating epithelial cells. J Cell Biol. 1989;108:1557-1565 (Pubitemid 19097060)
26. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biology phenomenon with wide-ranging implication in tissue kinetics. Br J Cancer. 1972;26:239-257
27. Allen RT, Hunter WJ III, Agrawae DK. Morphological and biochemical characterization and analysis of apoptosis. J Pharmacol Toxical Meth. 1997;37: 215-228 (Pubitemid 27380389)
28. Cohen GM. Caspases: the executioners of apoptosis. Biochem J. 1997;326: 1-16 (Pubitemid 27386911)
29. Salvesen GS, Dixit V. Caspases: intracellular signaling by proteolysis. Cell. 1997;91:443-446 (Pubitemid 27508233)
30. Enari M, Sakahira H, Yokyoama H. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 1998;391:43-50 (Pubitemid 28079208)
31. Behrns KE, Schrum LW, Que FG, et al. Apoptosis: cell death by proteolytic scalpel. Surgery. 1999;125:463-468 (Pubitemid 29421031)
32. Los M, Van de Craen M, Penning LC, et al. Requirement of an ICE/CED-3 protease for Fas/APO-1 mediated apoptosis. Nature. 1995;375:81-83
33. Piguet PF, Vesin C, Donati Y, et al. TNF-induced enterocyte apoptosis and detachment in mice: induction of caspases and prevention by a caspase inhibitor. Z VAD-fmk Lab Invest. 1999;79:495-500 (Pubitemid 29190439)
34. Farber A, Connors JP, Friedlander RM, et al. A specific inhibitor of apoptosis decreases tissue injury after intestinal ischemia-reperfusion in mice. J Vasc Surg. 1999;30:752-760 (Pubitemid 29487569)
35. Chiappa A, Makuuchi M, Zbar AP, et al. Comparison of continuous versus intermittent hepatic pedicle clamping in an experimental model. Hepato-Gastroenterol. 2001;48:1416-1420 (Pubitemid 33010437)
36. Man K, Fan St, Ng IO, et al. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumor by a randomized study. Ann Surg. 1997;226: 704-711
37. Man K, Fan ST, Ng IO, et al. Tolerance of the liver to intermittent Pringle maneuver in hepatectomy for liver tumors. Arch Surg. 1999;134: 535-539
38. Alho AM, Underhill CB. The hyaluronate receptor is preferentially expressed on proliferating epithelial cells. J Cell Biol. 1989;108:1557-1565 (Pubitemid 19097060)
39. Uff CR, Reid SD, Wood RFM. The hyaluronan receptor. J Cell Sci. 1992;103:293-298